These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 476649)
1. Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid. Stewart DJ; Benvenuto JA; Leavens M; Hall SW; Benjamin RS; Plunkett W; McCredie KB; Burgess MA; Loo TL Cancer Res; 1979 Oct; 39(10):4119-22. PubMed ID: 476649 [TBL] [Abstract][Full Text] [Related]
2. Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans. Rosenblum MG; Stewart DJ; Yap BS; Leavens M; Benjamin RS; Loo TL Cancer Res; 1981 Feb; 41(2):459-62. PubMed ID: 7448791 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and disposition of 3-deazauridine in humans. Benvenuto JA; Hall SW; Farquhar D; Stewart DJ; Benjamin RS; Loo TL Cancer Res; 1979 Feb; 39(2 Pt 1):349-52. PubMed ID: 761206 [TBL] [Abstract][Full Text] [Related]
4. High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells. Plunkett W; Benvenuto JA; Stewart DJ; Loo TL Cancer Treat Rep; 1979 Mar; 63(3):415-20. PubMed ID: 284846 [TBL] [Abstract][Full Text] [Related]
5. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells. Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947 [TBL] [Abstract][Full Text] [Related]
6. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration]. Nakagawa H; Fujita T; Izumoto S; Kubo S; Nakajima Y; Turuzono K Gan To Kagaku Ryoho; 1991 Jan; 18(1):103-9. PubMed ID: 1987891 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells. Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792 [TBL] [Abstract][Full Text] [Related]
8. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response. Moriconi WJ; Slavik M; Taylor S Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma. Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic analysis of ACNU in brain tumors (author's transl)]. Hara M; Takeuchi K No To Shinkei; 1979 Dec; 31(12):1289-93. PubMed ID: 526372 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study. Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031 [TBL] [Abstract][Full Text] [Related]
12. Cytidine and deoxycytidylate deaminase inhibition by uridine analogs. Drake JC; Hande KR; Fuller RW; Chabner BA Biochem Pharmacol; 1980 Mar; 29(5):807-11. PubMed ID: 20227960 [TBL] [Abstract][Full Text] [Related]
13. Concentration of vinblastine in human intracerebral tumor and other tissues. Stewart DJ; Lu K; Benjamin RS; Leavens ME; Luna M; Yap HY; Loo TL J Neurooncol; 1983; 1(2):139-44. PubMed ID: 6678966 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography. Plunkett W; Chubb S; Barlogie B J Chromatogr; 1980 Dec; 221(2):425-30. PubMed ID: 6938519 [No Abstract] [Full Text] [Related]
15. Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates. Berg SL; Aleksic A; McGuffey L; Dauser R; Nuchtern J; Bernacky B; Blaney SM Cancer Chemother Pharmacol; 2004 Aug; 54(2):127-30. PubMed ID: 15150671 [TBL] [Abstract][Full Text] [Related]
16. Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosamine. Jackson RC; Williams JC; Weber G Cancer Treat Rep; 1976 Jul; 60(7):835-43. PubMed ID: 188552 [TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model. Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910 [TBL] [Abstract][Full Text] [Related]
18. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts. Grant S; Cadman E Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541 [TBL] [Abstract][Full Text] [Related]
19. The disposition of 3-deazauridine in mice. Cysyk RL; Gormley PE; D'Anna ME; Adamson RH Drug Metab Dispos; 1978; 6(2):125-32. PubMed ID: 26526 [No Abstract] [Full Text] [Related]
20. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration. Kraft SL; Gavin PR; Leathers CW; DeHaan CE; Bauer WF; Miller DL; Dorn RV; Griebenow ML Cancer Res; 1994 Mar; 54(5):1259-63. PubMed ID: 8118814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]